Latest period
$56.28B
YoY change
+0.0%
5Y CAGR
-2.9%
Peak year (2017)
$70.28B
Latest annual
$59.02B
Total Assets history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $59.02B
Total Assets growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +0.0%
Total Assets history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $59.02B | +0.0% | +$28.00M | ||
| 2024 | $58.99B | -5.0% | −$3.13B | ||
| 2023 | $62.13B | -1.7% | −$1.05B | ||
| 2022 | $63.17B | -7.0% | −$4.78B | ||
| 2021 | $67.95B | -0.7% | −$455.00M | ||
| 2020 | $68.41B | +11.0% | +$6.78B | ||
| 2019 | $61.63B | -3.2% | −$2.05B | ||
| 2018 | $63.67B | -9.4% | −$6.61B | ||
| 2017 | $70.28B | +23.4% | +$13.31B | ||
| 2016 | $56.98B | +10.2% | +$5.26B | ||
| 2015 | $51.72B | +49.2% | +$17.05B | ||
| 2014 | $34.66B | +53.5% | +$12.09B | ||
| 2013 | $22.58B | +6.3% | +$1.34B | ||
| 2012 | $21.24B | +22.8% | +$3.94B | ||
| 2011 | $17.30B | +49.3% | +$5.71B | ||
| 2010 | $11.59B | +19.5% | +$1.89B | ||
| 2009 | $9.70B | +39.8% | +$2.76B | ||
| 2008 | $6.94B | +18.9% | +$1.10B | ||
| 2007 | $5.83B | +42.8% | +$1.75B | ||
| 2006 | $4.09B | +8.5% | +$319.67M | ||
| 2005 | $3.77B | +74.7% | +$1.61B | ||
| 2004 | $2.16B | +38.7% | +$601.24M | ||
| 2003 | $1.55B | +20.7% | +$266.54M | ||
| 2002 | $1.29B | +62.1% | +$493.40M | ||
| 2001 | $794.79M | +17.2% | +$116.69M | ||
| 2000 | $678.10M | +55.2% | +$241.29M | ||
| 1999 | $436.81M | -10.5% | −$50.99M | ||
| 1998 | $487.80M | +38.5% | +$135.70M | ||
| 1997 | $352.10M | +13.3% | +$41.40M | ||
| 1996 | $310.70M | +86.4% | +$144.00M | ||
| 1995 | $166.70M | +62.8% | +$64.30M | ||
| 1994 | $102.40M | — | — | ||
| 1992 | $146.80M | +35.1% | +$38.10M | ||
| 1991 | $108.70M | +769.6% | +$96.20M | ||
| 1990 | $12.50M | — | — |
- 2025$59.02B+0.0%
- 2024$58.99B-5.0%
- 2023$62.13B-1.7%
- 2022$63.17B-7.0%
- 2021$67.95B-0.7%
- 2020$68.41B+11.0%
- 2019$61.63B-3.2%
- 2018$63.67B-9.4%
- 2017$70.28B+23.4%
- 2016$56.98B+10.2%
- 2015$51.72B+49.2%
- 2014$34.66B+53.5%
- 2013$22.58B+6.3%
- 2012$21.24B+22.8%
- 2011$17.30B+49.3%
- 2010$11.59B+19.5%
- 2009$9.70B+39.8%
- 2008$6.94B+18.9%
- 2007$5.83B+42.8%
- 2006$4.09B+8.5%
- 2005$3.77B+74.7%
- 2004$2.16B+38.7%
- 2003$1.55B+20.7%
- 2002$1.29B+62.1%
- 2001$794.79M+17.2%
- 2000$678.10M+55.2%
- 1999$436.81M-10.5%
- 1998$487.80M+38.5%
- 1997$352.10M+13.3%
- 1996$310.70M+86.4%
- 1995$166.70M+62.8%
- 1994$102.40M—
- 1992$146.80M+35.1%
- 1991$108.70M+769.6%
- 1990$12.50M—
Total Assets values are taken from Gilead Sciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported total assets is $56.28B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) total assets totalled $59.02B – edged up 0.0% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences total assets expanded at a -2.9% compound annual rate, with a net decline across the window.
Gilead Sciences total assets declined from $70.28B in 2017 to $59.02B in 2025, a 16.0% drawdown.
Across the available history, total assets reached its high of $70.28B in 2017 and its low of $12.50M in 1990.
Gilead Sciences Total Assets by Year
Gilead Sciences Total Assets 2025: $59.02B
Gilead Sciences posted total assets of $59.02B in 2025, edged up 0.0% from 2024.
Gilead Sciences Total Assets 2024: $58.99B
In 2024, Gilead Sciences reported total assets of $58.99B, declined 5.0% below 2023.
Gilead Sciences Total Assets 2023: $62.13B
Gilead Sciences total assets in 2023 was $62.13B, edged down 1.7% below 2022.
Gilead Sciences Total Assets 2022: $63.17B
2022's total assets for Gilead Sciences came in at $63.17B, declined 7.0% below 2021.
Gilead Sciences Total Assets 2021: $67.95B
Gilead Sciences total assets in 2021 was $67.95B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Total Assets
Healthcare peers of Gilead Sciences (GILD), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation